Company intelligence / Profile preview

Foresight Therapeutics

Hefei, Anhui, China

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Foresight Therapeutics is a private biotech company in Hefei, China focused on early-stage drug discovery. Publicly visible information indicates the company is pursuing small-molecule programs including cardiac myosin inhibitors for hypertrophic cardiomyopathy and Werner syndrome ATP-dependent helicase (WRN) inhibitors for cancer. The company appears to operate primarily as a research-stage therapeutics developer rather than a commercial-stage pharmaceutical business. Corporate registry information shows it is an active operating entity founded in 2023 and owned by Jiangsu Foresight Biotechnology.

Therapeutic areas: CardiovascularOncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Foresight Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Foresight Therapeutics.

Explore the full profile